National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to health care
Data
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- All-Payer Claims Database
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- AHRQ Quality Indicator Tools for Data Analytics
- State Snapshots
- United States Health Information Knowledgebase (USHIK)
- Data Sources Available from AHRQ
Search All Research Studies
AHRQ Research Studies Date
AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results
1 to 1 of 1 Research Studies DisplayedFreburger JK, Ellis AR, Wang L
Comparative effectiveness of iron and erythropoiesis-stimulating agent dosing on health-related quality of life in patients receiving hemodialysis.
The researchers examined the independent associations of bolus versus maintenance iron dosing and high versus low erythropoiesis-stimulating agents (ESA) dosing on health-related quality of life (HRQoL). They found that for individuals with low baseline hemoglobin levels, higher ESA dosing and bolus iron dosing were associated with slightly higher HRQoL scores in follow-up.
AHRQ-funded; 29020050040I.
Citation: Freburger JK, Ellis AR, Wang L .
Comparative effectiveness of iron and erythropoiesis-stimulating agent dosing on health-related quality of life in patients receiving hemodialysis.
Am J Kidney Dis 2016 Feb;67(2):271-82. doi: 10.1053/j.ajkd.215.09.011.
.
Am J Kidney Dis 2016 Feb;67(2):271-82. doi: 10.1053/j.ajkd.215.09.011.
.
Keywords: Comparative Effectiveness, Quality of Life, Kidney Disease and Health, Outcomes, Health Status